The 2025 American Academy of Neurology (AAN) Conference took place in San Diego, California, from April 5 to 9. This post-conference report highlights key developments across several neurological conditions, including the treatment landscapes for Alzheimer's disease, migraine, multiple sclerosis, myasthenia gravis, and Parkinson's disease. It also covers discussions on diversity, equity, and inclusion (DEI), disease burden, biomarker utilization, and the potential applications of artificial intelligence in neurology.

Indications covered:

Alzheimer’s Disease 

Amyotrophic Lateral Sclerosis

Epilepsy

Huntington’s Disease

Migraine and other headaches

Multiple Sclerosis

Multiple System atrophy

Myasthenia Gravis

Narcolepsy

Pain

Parkinson’s Disease

For the full report, please download the PDF version at the top of this page.